Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Praluent
Praluent
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Repatha
Amgen
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?
Bidness, ETC
Mon, 08/31/15 - 11:13 am
PCSK9 inhibitors
Amgen
Regeneron
Repatha
Praluent
Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Bizjournals.com
Sun, 08/30/15 - 02:04 pm
Alnylam
Amgen
The Medicines Company
PCSK9 inhibitors
ALN-PCSsc
Repatha
Praluent
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
drug pricing
Repatha
Praluent
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
CVS
PCSK9 inhibitors
formulary
Sanofi
Regeneron
Praluent
Amgen
Repatha
Will Regeneron's New Drug Break The Bank?
Motley Fool
Wed, 08/5/15 - 09:28 am
Regeneron
Praluent
drug pricing
Sanofi
Sanofi draws a $14,600 line in the sand for Praluent payer fight
Fierce Pharma Marketing
Tue, 07/28/15 - 10:22 am
Sanofi
Praluent
Repatha
Amgen
Regeneron
drug pricing
PCSK9 inhibitors
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Barron's
Mon, 07/27/15 - 01:55 pm
Regeneron
Esperion Therapeutics
Sanofi
Praluent
Amgen
Repatha
ETC-1002
Docs are Excited About Prescribing Those New Cholesterol Drugs: Survey
WSJ Pharmalot
Fri, 07/24/15 - 03:47 pm
physicians
PCSK9 inhibitors
Praluent
Repatha
Amgen
Sanofi
Regeneron
Sanofi's big new cholesterol drug wins European green light
Yahoo/Reuters
Fri, 07/24/15 - 10:05 am
Praluent
Sanofi
Regeneron
Europe
PCSK9 inhibitors
Amgen
Repatha
Praluent's FDA review looms, but questions persist
Medical Marketing and Media
Wed, 07/22/15 - 09:45 pm
Praluent
FDA
PCSK9 inhibitors
Sanofi
Regeneron
Sanofi cholesterol drug, GSK malaria shot may get EU okay Friday
Yahoo/Reuters
Tue, 07/21/15 - 10:30 am
GSK
Sanofi
Europe
Praluent
malaria
PCSK9 inhibitors
Repatha
Amgen
Why July Will Be an Exciting Month for Regeneron Pharmaceuticals
Motley Fool
Sun, 07/12/15 - 09:41 am
Regeneron
FDA
Sanofi
Praluent
Sanofi, Regeneron say Japan study shows Praluent drug lowers cholesterol
Yahoo/Reuters
Thu, 07/9/15 - 10:14 am
Sanofi
Regeneron
Japan
Praluent
Why Praluent Could Be Blockbuster For Regeneron
Seeking Alpha
Tue, 07/7/15 - 12:31 pm
Praluent
Regeneron
What Is Beyond Vision-Loss Blockbuster For Regeneron?
Investors.com
Wed, 07/1/15 - 10:49 pm
Regeneron
Eylea
Praluent
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Amgen
Sanofi
Regeneron
Repatha
Praluent
PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Amgen
Regeneron
Sanofi
Repatha
Praluent
FDA
advisory panels
PCSK9 inhibitors
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »